Literature DB >> 22036933

Classification and management of the unstable total hip arthroplasty.

Glenn D Wera1, Nick T Ting, Mario Moric, Wayne G Paprosky, Scott M Sporer, Craig J Della Valle.   

Abstract

Seventy-five total hip arthroplasty revisions for instability were classified into 6 primary etiologies: I, acetabular component malposition; II, femoral component malposition; III, abductor deficiency; IV, impingement; V, late wear; or VI, unresolved etiology. The most common etiologies were cup malposition (type I; 33%) and abductor deficiency (type III; 36%). At a mean of 35.3 months, 11 redislocations occurred (14.6%). Acetabular revisions were protective against redislocation (P < .015). The number of previous operations (P = .0379) and previously failed constrained liners (P < .02) were risk factors for failure. Tripolar constrained liners demonstrated improved survivorship vs locking ring types (P < .02); cemented constrained liners failed more often than modular constrained liners (P < .0018). The highest risk of failure was in patients with abductor insufficiency with revisions for other etiologies having a success rate of 90%. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22036933     DOI: 10.1016/j.arth.2011.09.010

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  27 in total

1.  A critical analysis of radiographic factors in patients who develop dislocation after elective primary total hip arthroplasty.

Authors:  Marion Opperer; Yuo-yu Lee; Francisco Nally; Alvaro Blanes Perez; Kaveh Goudarz-Mehdikhani; Alejandro Gonzalez Della Valle
Journal:  Int Orthop       Date:  2015-10-27       Impact factor: 3.075

2.  [Diagnostics and therapy of luxation after total hip arthroplasty].

Authors:  B Preininger; F Haschke; C Perka
Journal:  Orthopade       Date:  2014-01       Impact factor: 1.087

3.  Trunnion Failure of the Recalled Low Friction Ion Treatment Cobalt Chromium Alloy Femoral Head.

Authors:  Kenneth L Urish; Brian R Hamlin; Anton Y Plakseychuk; Timothy J Levison; Genymphas B Higgs; Steven M Kurtz; Anthony M DiGioia
Journal:  J Arthroplasty       Date:  2017-04-08       Impact factor: 4.757

4.  Fluoroscopy assessment during anterior minimally invasive hip replacement is more accurate than with the posterior approach.

Authors:  Weifeng Ji; Nathaniel Stewart
Journal:  Int Orthop       Date:  2015-05-10       Impact factor: 3.075

Review 5.  Total hip arthroplasty instability treatment without dual mobility cups: brief overview and experience of other options.

Authors:  Luigi Zagra; Eleonora Caboni
Journal:  Int Orthop       Date:  2017-01-14       Impact factor: 3.075

6.  Are Readmissions After THA Preventable?

Authors:  Douglas S Weinberg; Matthew J Kraay; Steven J Fitzgerald; Vasu Sidagam; Glenn D Wera
Journal:  Clin Orthop Relat Res       Date:  2016-11-11       Impact factor: 4.176

7.  Soft tissue tension is four times lower in the unstable primary total hip arthroplasty: does this comparison make sense?

Authors:  Jian Zhou; Wanchun Wang; Ruiqi Chen; Shibin Tao; Boyu Zhang; Zhanyu Yang
Journal:  Int Orthop       Date:  2018-05-24       Impact factor: 3.075

8.  Does fluoroscopy improve acetabular component placement in total hip arthroplasty?

Authors:  Brandon S Beamer; Jordan H Morgan; Christopher Barr; Michael J Weaver; Mark S Vrahas
Journal:  Clin Orthop Relat Res       Date:  2014-09-20       Impact factor: 4.176

9.  Acetabular cup positioning in revision total hip arthroplasty with Paprosky type III acetabular defects: Martell radiographic analysis.

Authors:  Ho-Rim Choi; David Anderson; Scott Foster; Matthew Beal; Jo Ann Lee; Christopher Barr; Henrik Malchau; Joseph McCarthy; Young-Min Kwon
Journal:  Int Orthop       Date:  2013-07-24       Impact factor: 3.075

10.  The focally constrained liner is a reasonable option for revision of unstable total hip arthroplasty.

Authors:  Tatu J Mäkinen; Simcha G Fichman; Wael A Rahman; Tomas Amenabar; Oleg Safir; Allan E Gross; Paul R T Kuzyk
Journal:  Int Orthop       Date:  2015-12-23       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.